|
|
Over-expression of microRNA-494 up-regulates hypoxia-inducible factor-1 alpha expression via PI3K/Akt pathway and protects against hypoxia-induced apoptosis
|
|
|
|
|
نویسنده
|
sun g. ,zhou y. ,li h. ,guo y. ,shan j. ,xia m. ,li y. ,li s. ,long d. ,feng l.
|
منبع
|
journal of biomedical science - 2013 - دوره : 20 - شماره : 1
|
چکیده
|
Background: hypoxia-inducible factor-1 alpha (hif-1) is one of the key regulators of hypoxia/ischemia. microrna-494 (mir-494) had cardioprotective effects against ischemia/reperfusion (i/r)-induced injury,but its functional relationship with hif-1 was unknown. this study was undertaken to determine if mir-494 was involved in the induction of hif-1. results: quantitative rt-pcr showed that mir-494 was up-regulated to peak after 4 hours of hypoxia in human liver cell line l02. to investigate the role of mir-494,cells were transfected with mir-494 mimic or mir-negative control,followed by incubation under normoxia or hypoxia. our results indicated that overexpression of mir-494 significantly induced the expression of p-akt,hif-1 and ho-1 determined by qrt-pcr and western blot under normoxia and hypoxia,compared to negative control (p < 0.05). while ly294002 treatment markedly abolished mir-494-inducing akt activation,hif-1 and ho-1 increase under both normoxic and hypoxic conditions (p < 0.05). moreover,apoptosis detection using annexin v indicated that overexpression of mir-494 significantly decreased hypoxia-induced apoptosis in l02 cells,compared to control (p < 0.05). mir-494 overexpression also decreased caspase-3/7 activity by 1.27-fold under hypoxia in l02 cells. conclusions: overexpression of mir-494 upregulated hif-1 expression through activating pi3k/akt pathway under both normoxia and hypoxia,and had protective effects against hypoxia-induced apoptosis in l02 cells. thus,these findings suggested that mir-494 might be a target of therapy for hepatic hypoxia/ischemia injury. © 2013sun et al.; licensee biomed central ltd.
|
کلیدواژه
|
Apoptosis; Hypoxia-inducible factor-1 alpha; L02 cells; MicroRNA-494; PI3K/Akt
|
آدرس
|
key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province, China, key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province, China, key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province, China, key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province,china,regenerative medicine research center,west china hospital,sichuan university,chengdu,sichuan,province, China, key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province,china,regenerative medicine research center,west china hospital,sichuan university,chengdu,sichuan,province, China, key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province, China, key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province,china,chinese cochrane centre,west china hospital,sichuan university,chengdu,sichuan,province, China, key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province, China, key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province, China, key laboratory of transplant engineering and immunology of health,ministry of china,west china hospital,chengdu 610041,sichuan,province,china,regenerative medicine research center,west china hospital,sichuan university,chengdu,sichuan,province, China
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|